Table 1.
Characteristics of the 92 patients at T0 according to plasma HIV viremia control (SSP, VP and PSP). Data are expressed as median and interquartile range (IQR)
| SSP (40 pts) | VP (33 pts) | SPS (19 pts) | |
|---|---|---|---|
| Age (years) | 47 (39–59 | 40 (32–47) | 43 (38–49) |
| CD4 + cell count/mm3 | 605 (475–785) | 570 (410–662) | 530 (370–827) |
| CD4+ cell percentage | 27.5 (22.5–36) | 23 (19.7–30) | 24 (20–28.2) |
| CD8+ cell count/mm | 849 (602–1227) | 1106 (1012–1464) | 1240 (854–1490) |
| CD8 + cell percentage | 43 (34.5–51) | 51 (47–60) | 48 (42–62) |
| CD4/CD8 ratio | 0.8 (0.5–1) | 0.4 (0.4–0.6) | 0.6(0.3–0.7) |
| CD4+ cell count at nadir (cells/mm3) | 290 (132–405) | 460 (322–535) | 260 (88–355) |
| Plasma HIV-RNA value in the 24 month prior T0 log (Log10 copies/ml) | – | 4.57(3.99–4.8) | – |
| Plasma HIV-RNA value in the 24 month prior T1 (Log10 copies/ml) | – | 4.44 (3.77–4.83) | – |
T0: time of the first saliva sampling after 24 months of plasma HIV RNA control analysis
T1: time of the second saliva testing, 24 months after T0
SSPs HIV successfully suppressed patients, VPs HIV viremic patients, PSPs HIV partially suppressed patients